The Journal of Experimental Medicine
for flow cytometry > invitrogen
  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents

Published 1 December 2003. doi:10.1084/jem.20031162
This Article
Right arrow Full Text
Right arrow Full Text (PDF, 184K)
Right arrow PPT slides of all figures
Right arrow Alert me when this article is cited
Right arrow Citation Map
Services
Right arrow Email this article
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new content in the JEM
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kelly, B. L.
Right arrow Articles by Locksley, R. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kelly, B. L.
Right arrow Articles by Locksley, R. M.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?
© Rockefeller University Press, 0022-1007/2003/12/1689 $5.00
The Journal of Experimental Medicine, Volume 198, Number 11, 1689-1698

Leishmania major LACK Antigen Is Required for Efficient Vertebrate Parasitization

Ben L. Kelly, Daniel B. Stetson and Richard M. Locksley

Howard Hughes Medical Institute, Department of Medicine and Department of Microbiology/Immunology, University of California San Francisco, San Francisco, CA 94143

Address correspondence to Richard M. Locksley, University of California San Francisco Medical Center, Room C-443, 521 Parnassus Avenue, San Francisco, CA 94143. Phone: (415) 476-5859; Fax: (415) 476-9364; email: locksley{at}medicine.ucsf.edu

The Leishmania major LACK antigen is a key target of the immune response in susceptible BALB/c mice and remains a viable vaccine candidate for human leishmaniasis. We describe the genomic organization of the four lack genes in the L. major diploid genome together with results of selected lack gene targeting. Parasites containing a single lack gene in either the upstream or downstream locus grew comparably to wild-type promastigotes in vitro, but failed to parasitize BALB/c mice efficiently, even in a T cell–deficient environment. The replication of single copy lack mutants as amastigotes was attenuated in macrophages in vitro, and parasites failed to increase in numbers in immunodeficient mice, despite their persistence over months. Complementation with an additional lack copy was sufficient to induce robust lesion development, which also occurred using parasites with two lack genes. Conversely, attempts to generate lack-null parasites failed, suggesting that LACK is required for parasite viability. These data suggest that LACK is critical for effective mammalian parasitization and thus represents a potential drug target for leishmaniasis.

Key Words: Leishmania major • LACK • protozoa • gene targeting • WD repeat proteins


Abbreviations used in this paper: GFP, green fluorescent protein; PKC, protein kinase C; PNA, peanut agglutinin.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:



  Home | Help | Feedback | Subscriptions | Archive | Search
TABLE OF CONTENTS